Almac - International Pharmaceutical Industry

News

Almac Group Appoints Three Vice Presidents

Almac Group, the global contract development and manufacturing organisation, has announced the appointment of three new Vice Presidents within its Pharma Servic...

25 July 2018 News Almac | appoints

Continue Reading →

News

Almac Group Appoints David Taylor as Head of Manufacturing Operations

David Taylor joined the Almac Group in November 2017 as Head of Manufacturing, Almac Sciences. He is tasked with the overall accountability for small molecul...

1 May 2018 News Almac | David

Continue Reading →

News

Almac Discovery to share latest developments in first-in-class DUB inhibitors at the at 8th Proteasome and Autophagy Congress

Almac Discovery, a biopharmaceutical company with a key research focus in the area of deubiquitylating enzyme therapeutic discovery, has had its work recognised ...

24 April 2018 News Almac | Autophagy

Continue Reading →

News

Almac Diagnostics Validates Illumina TruSight® Tumor 170 Cancer Mutation Panel for Prospective Testing in Clinical Trials

CLIA compliant assay, for clinical trial use, including US and Europe Validation performance specifications for review on Almac Diagnostics...

17 April 2018 News Almac | diagnostics

Continue Reading →

Uncategorised

Almac Group Expands with Opening of £20 million Cold Chain Facility

Craigavon, N.I., 28 February 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, today announced the completion of a £...

28 February 2018 Uncategorised | News Almac | cold chain

Continue Reading →